Adrenal tumor microenvironment: hormone–immune crosstalk, molecular heterogeneity, and immunotherapeutic opportunities - Top-Institutions - MDSpire

Adrenal tumor microenvironment: hormone–immune crosstalk, molecular heterogeneity, and immunotherapeutic opportunities

  • By

  • Shuang Chen

  • Xin Gao

  • June 26, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University Hospital Würzburg
    University Hospital Würzburg

    Würzburg, Bavaria

    Key Differentiators

    • Endocrinology
    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Endocrinology

  • #3

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Oncology
    • Endocrinology

  • #4

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Oncology
    • Endocrinology

  • #5

    University of Colorado School of Medicine
    University of Colorado School of Medicine

    Aurora, Colorado

    Key Differentiators

    • Surgery
    • Endocrinology

Original Source(s)

Adrenal tumor microenvironment: hormone–immune crosstalk, molecular heterogeneity, and immunotherapeutic opportunities

  • by Shuang Chen, Xin Gao

  • June 26, 2026

Related Content

Editorial: EBV strategies to counteract the immune response

Real-world efficacy and safety of PD-1 inhibitors in patients living with HIV and cancer: a retrospective cohort study

Metformin inhibits small intestinal neuroendocrine tumor growth in vivo